[Form 4] BrightView Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

BrightView Holdings, Inc. (BV) director Jane L. Bomba Okun received 2,052 shares of common stock as vested director compensation on 09/30/2025. The Form 4 shows the shares were issued in lieu of cash at an indicated price of $13.40 per share. After the transaction the reporting person beneficially owned 118,647 shares in total. The filing was signed on behalf of the reporting person by an attorney-in-fact on 10/01/2025 and identifies the relationship as a director filing on behalf of one reporting person.

Positive

• Director alignment: Shares issued as compensation increase the director's equity stake, aligning interests with shareholders.
• Transparent disclosure: Form 4 timely reports the issuance and post-transaction beneficial ownership of 118,647 shares.

Negative

• Cash conservation implication: Issuing equity in lieu of cash may slightly dilute existing shareholders.
• Limited detail on valuation: The form lists a price of $13.40 but provides no explanation of how that figure was determined.

Insights

Securities Analyst

TL;DR: Director received routine equity compensation; transaction is immaterial to shareholders given size relative to total holdings.

The Form 4 documents a non-derivative acquisition of 2,052 common shares as vested director compensation, issued in lieu of cash. The price listed ($13.40) likely reflects the accounting value for the grant but does not imply a market purchase. The reporting person now holds 118,647 shares, indicating this grant increased insider ownership modestly. This is a standard governance disclosure with limited market impact.

Corporate Governance Expert

TL;DR: This is a routine director compensation disclosure; it signals alignment through equity but is not a material corporate event.

The explanatory note states these were vested shares issued as director compensation in lieu of cash, a common practice to align directors with shareholder interests. The filing is straightforward, lists the reporting person as a director, and does not indicate any sales, option exercises, or changes to governance arrangements. No material governance concern or change is evident from this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Bomba Jane L Okun

(Last) (First) (Middle)

C/O BRIGHTVIEW HOLDINGS, INC.

980 JOLLY ROAD, SUITE 300

(Street)

BLUE BELL PA 19422

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightView Holdings, Inc. [ BV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A(1)		2,052	A	$13.4	118,647	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vested shares of Issuer common stock issued as director compensation in lieu of cash.

	/s/ Jonathan M. Gottsegen, as Attorney-in-Fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BrightView (BV) director Jane L. Bomba Okun report on the Form 4?

She reported acquiring 2,052 shares of common stock as vested director compensation on 09/30/2025, increasing her beneficial ownership to 118,647 shares.

Was the Form 4 transaction a purchase or compensation issuance for BV?

The filing states the shares represent vested shares issued as director compensation in lieu of cash, not a market purchase.

What price is shown for the shares on the BV Form 4?

The form lists a price of $13.40 per share for the reported issuance.

When was the BV Form 4 signed and filed?

The signature by an attorney-in-fact is dated 10/01/2025 and the transaction date is 09/30/2025.

Does this Form 4 indicate any sales or option exercises by the director?

No. The filing records only an acquisition of vested common stock and no disposals or derivative transactions.